Takeda Pharmaceutical (TAK) Other Non-Current Liabilities: 2017-2025

Historic Other Non-Current Liabilities for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $541.9 million.

  • Takeda Pharmaceutical's Other Non-Current Liabilities fell 0.94% to $541.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $541.0 million, marking a year-over-year decrease of 0.94%. This contributed to the annual value of $541.9 million for FY2025, which is 3.45% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Other Non-Current Liabilities stood at $541.9 million for FY2025, which was down 3.45% from $561.2 million recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Other Non-Current Liabilities peaked at $561.2 million during FY2024, and registered a low of $365.5 million during FY2021.
  • In the last 3 years, Takeda Pharmaceutical's Other Non-Current Liabilities had a median value of $541.9 million in 2025 and averaged $505.8 million.
  • Per our database at Business Quant, Takeda Pharmaceutical's Other Non-Current Liabilities dropped by 10.89% in 2023 and then soared by 35.47% in 2024.
  • Takeda Pharmaceutical's Other Non-Current Liabilities (MRY) stood at $365.5 million in 2021, then grew by 27.20% to $464.9 million in 2022, then decreased by 10.89% to $414.3 million in 2023, then surged by 35.47% to $561.2 million in 2024, then decreased by 3.45% to $541.9 million in 2025.
  • Its last three reported values are $541.9 million in FY2025, $561.2 million for FY2024, and $414.3 million during FY2023.